Other Species / Isoforms
  AurC (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S32-p
QTAQQPSsPAMRRLT
0 1
AurC (human) QTAQQPSsPAMRRLT S32-p
AurC iso2 (human) gap -
AurC (mouse) ___MEPSTSTRKHFT T5
AurC (rat) SVLKDPKFHFSCGIP F24
S77-p
ALKVLFKsQIEKEGL
0 1
AurC (human) ALKVLFKsQIEKEGL S77-p
AurC iso2 (human) ALKVLFKSQIEKEGL S43
AurC (mouse) ALKVLFKSEIEKEGL S50
AurC (rat) ALKVLFKSEIGKEGL S76
K197-ac
HTPSLRRktMCGtLD
0 1
AurC (human) HTPSLRRktMCGtLD K197-ac
AurC iso2 (human) HTPSLRRKtMCGTLD K163
AurC (mouse) HTPSLRRKtMCGtLD K170
AurC (rat) HTPSLRRKTMCGTLD K196
T198-p
TPSLRRktMCGtLDY
Upstream
Downstream
6 90
AurC (human)
T198-p
AurC (mouse)
T171-p
AurC (rat)
T197-p
Effects on Modified Protein
  • enzymatic activity, induced
Treatment
  • MLN8054
  • ZK-Thiazolidinone
AurC (human) TPSLRRktMCGtLDY T198-p
AurC iso2 (human) TPSLRRKtMCGTLDY T164-p
AurC (mouse) TPSLRRKtMCGtLDY T171-p
AurC (rat) TPSLRRKTMCGTLDY T197
T202-p
RRktMCGtLDYLPPE
Upstream
Downstream
3 21
Effects on Modified Protein
  • enzymatic activity, induced
Treatment
  • MLN8054
AurC (human) RRktMCGtLDYLPPE T202-p
AurC iso2 (human) RRKtMCGTLDYLPPE T168
AurC (mouse) RRKtMCGtLDYLPPE T175-p
AurC (rat) RRKTMCGTLDYLPPE T201
S271-p
LGARDLIsRLLRYQP
0 1
AurC (human) LGARDLIsRLLRYQP S271-p
AurC iso2 (human) LGARDLISRLLRYQP S237
AurC (mouse) AGAQDLISKLLRYHP S244
AurC (rat) AGAQDLISKLLRHHP S270